Hazem M. Mousa

Matrix metalloproteinase 9 positivity predicts long term decreased tear production

Matias Soifer, Hazem M. Mousa, Sandra S. Stinnett et al. · The Ocular Surface · 2020 · 28 citations

Inflammation, Metalloprotein, Pathology +7

A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America

Matias Soifer, Arianna Tovar, Margaret Wang et al. · The Ocular Surface · 2022 · 28 citations

Ocular Disease, Ophthalmology, Ocular Surface Diseases +5

Meibomian Gland Dysfunction: A Route of Ocular Graft-Versus-Host Disease Progression That Drives a Vicious Cycle of Ocular Surface Inflammatory Damage

Victor L. Perez, Hazem M. Mousa, Matias Soifer et al. · American Journal of Ophthalmology · 2022 · 22 citations · Full text

Inflammation, Ocular Disease, Autoimmune Disease +8

Ocular Surface Inflammatory Disorders (OSID): A Collective of Systemic Etiologies Which Cause or Amplify Dry Eye Syndrome

Matias Soifer, Nadim S. Azar, Hazem M. Mousa et al. · Frontiers in Medicine · 2022 · 20 citations · Full text

Inflammation, Systemic Disorders, Ocular Disease +15

Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases

Alfonso L. Sabater, Hazem M. Mousa, Xavier Quinones et al. · International Ophthalmology · 2021 · 12 citations

Tissue Engineering, Regenerative Medicine, Ocular Disease +9